echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Nature publishes two articles in a row: the new technology "FIND-seq" detects cells that were previously difficult to distinguish

    Nature publishes two articles in a row: the new technology "FIND-seq" detects cells that were previously difficult to distinguish

    • Last Update: 2023-02-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
      

    Rare cell types can have undue effects on
    human health.
    Previous research has suggested that a subset of astrocytes — the astrocytes in the brain and spinal cord — may be responsible for multiple sclerosis (MS), a disease
    in which the immune system attacks the covering that protects nerves.
    But finding these rare cells isn't an easy task—to pinpoint them, researchers need to identify unique surface markers that distinguish these culprit cells from the rest
    .
    Single-cell RNA sequencing can help find them, even without distinguishing surface markers, but this technique can become very expensive
    .

    To address this problem, a team led by researchers at Brigham and Women's Hospital, one of the founding members of the Brigham Health Care System, developed a FIND-seq that combines nucleic acid cytometry, microfluidics, and droplet classification to isolate and analyze rare cells
    of interest based on the expression of mRNA biomarkers detected by digital droplet PCR.
    Using this approach, the team analyzed in detail the astrocytes population
    that drive inflammation and neurodegeneration of the central nervous system.
    When used in combination with other tools, FIND-seq identified signaling pathways controlled by the mineralocorticoid receptor NR3C2 and nuclear receptor co-inhibitory factor 2, which play an important role
    in the development of disease-causing astrocytes in mice and humans.
    In another study, researchers used FIND-seq to determine the mechanisms
    by which HIV is "hidden" in immune cells in patients receiving antiretroviral therapy.

    Dr.
    Francisco Quintana, corresponding author of BWH's Department of Neurology, said: "These findings identify new targets for therapeutic interventions for neurological diseases such as MS
    .
    " The team is working to develop new small molecules that could be used to treat this pathway
    .

    FIND-Seq article and read about its use in HIV research in a companion paper published in
    the same issue.

    Original search:

    1.
    Identification of astrocyte regulators by nucleic acid cytometry

    2.
    HIV silencing and cell survival signatures in infected T cell reservoirs


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.